MedTrace Logo

BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention

NCT00111566 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 624

Last updated 2013-11-28

No results posted yet for this study

Summary

This trial was designed to examine the efficacy of a brief versus a standard prolonged (18 hours) infusion of eptifibatide in preventing troponin I release following successful coronary stenting.

Conditions

Interventions

DRUG

eptifibatide

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • Cardiology Research UBC

    lead OTHER

Principal Investigators

  • Anthony Fung, MB,BS, FRCPC · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2007-07-31
Completion
2007-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00111566 on ClinicalTrials.gov